Prostaglandin F2\ g=a\(PGF2\g=a\) has regulatory (mainly luteolytic) effects in the ovary but the mechanism of action is not completely understood. Reverse transcriptase\p=n-\polymerase chain reaction (RT\p=n-\PCR)techniques were used to demonstrate the presence of mRNA encoding the PGF2\g=a\receptor (FP receptor) in human granulosa\p=n-\lutein cells. Specific primers for the amplification of cDNA were designed and yielded a single product of 696 bp corresponding to the FP receptor. The identity of this product was verified by sequencing. Fluprostenol, a selective FP receptor agonist, activated phospholipase C (PLC) and increased intracellular free calcium concentration, confirming the functional activation of the receptor. We have demonstrated by Western blotting that granulosa cells express PLC-\g=b\ and PLC-\g=g\ isoforms. The cells responded to pervanadate with increased PLC activity and increased tyrosine phosphorylation, demonstrating a functional PLC-\g=g\tyrosine kinase pathway. However, fluprostenol did not provoke any detectable tyrosine phosphorylation. Moreover, the effect of fluprostenol was inhibited through protein kinase C stimulation by phorbol 12,13\x=req-\ dibutyrate, and was not affected when cells were treated with phenylarsine oxide, which blocks tyrosine phosphorylation. These results suggest that the FP receptor activates PLC-\g=b\ rather than PLC-\g=g\ isoforms. Fluprostenol-induced activation was pertussis toxin resistant. Granulosa cells express G proteins of the Gq family (resistant to pertussis toxin) and mRNA for both G\ g=a\ q and G\g=a\11 has been identified by RT\p=n-\PCR.In conclusion, human granulosa cells have a functional FP receptor the effects of which are mediated through PLC-\g=b\ activation probably via Gq/11.
Introduction
Prostaglandins (PGs) are involved in the regulation of granu¬ losa and luteal cell function but their mechanism of action is not completely understood. PGE2 has luteotrophic effects both in vivo and in vitro (McNatty et al, 1975) and stimulates progesterone output by human granulosa cells obtained from follicles at different stages of development (McNatty et al, 1975) . The effect of PGE2 is associated with an increase in cyclic adenosine-3 ',5 '-monophosphate (cAMP) and is mediated by prostaglandin EP2 receptors coupled to adenylyl cyclase (Dennefors et al, 1982; Michael et al, 1993; López Bernal et al, 1995) . By contrast, the action of PGF2(1 appears to be more complex. In cultured human granulosa cells PGF2a inhibits progesterone output and antagonises the stimulatory effect of hCG (McNatty et al, 1975; Michael and Webley, 1991) ; a similar luteolytic effect has been described in several primate and non-primate species (Thomas et al, 1978; Hamberger et al, 1979; Pate and Condon, 1984) . The antigonadotrophic action of PGF2(1 may involve inhibitory effects at sites both before and after adenylyl cyclase activation, probably mediated by protein kinase C (PKC) activation (Michael and Webley, 1993) but it could also result from potentiation of the inhibitory effects of other luteolytic agents, for example endothelin-1 (Prins et al, 1994; Liebermann et al, 1996) . The presence of PGF2c( receptors (FP receptors) in human and non-primate granulosa-luteal cells has been demonstrated by binding studies (Powell et al, 1974) and the FP receptor has been cloned from ovarian complemen¬ tary DNA (cDNA) libraries in mice, rats and sheep (Lake et al, 1994; Kitanaka et al, 1994; Sakamoto et al, 1994; Sugimoto et al, 1994; Graves et al, 1995) . Ristimäki et al. (1997) have cloned a partial cDNA sequence of the FP receptor in human granulosa cells. The expression of mRNA encoding FP receptor was increased by hCG administration in vitro (Ristimäki et al, 1997) . FP receptors belong to the G protein-coupled receptor superfamily and they are thought to operate through activation of the inositol phospholipid pathway (Houmard el al, 1992) . The hydrolysis of phosphatidylinositol 4,5-bisphosphate by a phospholipase C (PLC) generates two molecules with second messenger function: inositol 1,4,5-trisphosphate which mobilizes calcium from the sarcoplasmic reticulum and 1,2diacylglycerol which activates PKC Houmard et al (1992) reported that PGF2o is a potent activator of PLC in a primate (rhesus monkeys) corpus luteum. Moreover, PGF2o increases intracellular free calcium ([Ca2+]¡) in human granulosa cells (Currie et al, 1992) . However, uncertainty remains as to whether PLC activation and changes in [Ca \ are required for PGF2(X to exert its luteolytic effect. For example, in marmoset monkeys in the late luteal phase PGF2(1 has a strong luteolytic and antigonadotrophic effect which apparently occurs without PLC activation (Michael and Webley, 1993) . Moreover, phosphatidylinositol hydrolysis can be catalysed not only by G protein-dependent PLC isoenzymes (PLC-ß family), but also by a variety of receptor-tyrosine kinase-dependent enzymes (PLC-family). It has been reported that PGF2(I rapidly in¬ creases tyrosine phosphorylation in some cell lines (Watanabe et al, 1994) but is not known whether this happens in granulosa cells.
The purpose of this paper was to investigate the second messenger pathway for FP receptors in cultured human granu¬ losa cells. Fluprostenol, a synthetic PGF2o analogue, which is a selective FP receptor agonist (Dukes et al, 1974; Carrasco et al, 1996) was used and its effects on PLC-ß and PLCactivation were studied. The presence of mRNA encoding the FP receptor was confirmed and mRNAs encoding two distinct G proteins, Ga and Gan, which are known to activate PLC-ß, were demonstrated.
Materials and Methods

Materials
Materials used in this study were purchased from the following sources: [JH]myo-inositol (1.5 TBq mmol1), horseradish-peroxidase-conjugated sheep anti-mouse IgG, horseradish-peroxidase-conjugated goat anti-rabbit IgG and enhanced chemiluminescense detection kits (ECL) were obtained from Amersham International pic (Amersham) . Oxytocin was from Calbiochem-Novabiochem (Nottingham). PGF2ll, sodium orthovanadate, phorbol 12,13-dibutyrate (PDBu), phenylarsine oxide (PAO), pertussis toxin, thapsigargin and fatty acid-free bovine serum albumin (BSA) were from Sigma Chemical Co. Ltd (Poole). Anti-phospholipase C antibodies Gl2 (PLC-ßl), Q-15 (PLC-ß2), C-20 (PLC-ß3), C-18 (PLC-ß4), 1249 (PLC-) and C-19 ( · 2) and their respec¬ tive cognate peptides were from Santa Cruz Biotechnology Inc. (Santa Cruz, CA). Anti-phosphotyrosine mouse monoclonal antibody 4G-10 was purchased from Upstate Biotechnology Incorporated (Lake Placid, NY). Fura-2-acetoxymethyl ester and Pluronic F-127 were obtained from Molecular Probes (Eugene, OR). Tissue culture reagents were from Life Technologies (Paisley). All other reagents were commercial preparations of the highest available purity. Fluprostenol was kindly supplied by R. Coleman (formerly at Glaxo, UK).
Preparation and incubation of human granulosa cells
Granulosa cells were collected with consent of the patients and approval by the Central Oxfordshire Ethics Committee from women undergoing routine oocyte retrieval for in vitro fertilization. Follicular growth was stimulated by daily injection of gonadotrophins in patients previously desensitized with a long course of GnRH (López Bernal et al, 1995) . Follicles were aspirated 35 h after administration of 10 000 iu of hCG (Profasi, Serono Labs UK, Ltd, Hertfordshire). After removal of any oocytes present, follicular fluids were centrifuged at 340 g at room temperature for 10 min through Ficoll-Paque (Pharmacia, St Albans) to remove blood cells. Granulosa cell layers were subsequently dispersed with collagenase (Sigma Co. Ltd, Poole; diluted to 300 U ml " ') and Trasylol (Bayer UK, Newbury; diluted to 100 UmL1) for 20 min at 37°C in 1 mmol CaCl2 1~\ Viability of cells after dispersion was 80% as detected by Trypan blue staining and the yield per patient was 0.4-1.5 x 106 cells.
Cells were seeded at 40 IO3 cells cm-2 in fibronectin- Immunodetection of phospholipase C PLC isoforms were detected by western blotting in mem¬ brane and cytosol fractions of granulosa cells essentially as described by Phaneuf et al (1996) . Proteins were separated by SDS-PAGE (7.5% acrylamide) for 45 min at 200 V, and trans¬ ferred to nitrocellulose using a Bio-Rad semi-dry electroblotting apparatus with 0.025 mol Tris 1~\ 0.2 mol glycine 1~\ 20% methanol, pH 8.6 at 13 V for 2 h. After transfer, the nitrocellulose papers were incubated in PBS-Tween (phosphate-buffered saline, Tween-20 0.1%, v/v), containing 2% skimmed milk overnight at room temperature. Nitrocellu¬ lose papers were then incubated with anti-phospholipase C antibodies at a 1:1000 dilution for 1 h at 4°C in PBS-Tween containing 0.15% skimmed milk. The blots were washed three times in PBS-Tween, and then incubated with goat anti-rabbit immunoglobulin G coupled to horseradish peroxidase at a 1:1000 dilution for 1 h at room temperature in PBS-Tween.
Finally the blots were washed three times in PBS. Chemiluminescense detection (ECL) was carried out according to the technical notes provided by Amersham, with Kodak X-Omat XAR film.
Tyrosine phosphorylation assay
Treatments with fluprostenol, pervanadate or oxytocin were carried out on granulosa cells grown on 25 cm2 plastic culture flasks as described by Carrasco et al. (1996) . Briefly, cells were washed with HBSS, then incubated with 1 µ fluprostenol or oxytocin I-for 30 min at 37°C, or with pervanadate (400 pmol sodium orthovanadate 1~, 2 mmol H202 1~J ) for 15 min at 37°C. The reactions were stopped by removing the medium and by washing with ice-cold HBSS. The cells were scraped from the flasks and pelleted by centrifugation at 1000 # for 15 min? The pellets were solubilised in SDS buffer contain¬ ing 8 mol urea 1_1 and heated at 95°C for 10 min before electrophoresis.
After transfer, the nitrocellulose was saturated with 10% BSA in PBS-Tween for 30 min at 4°C. Nitrocellulose papers were then incubated with anti-phosphotyrosine mouse mono¬ clonal antibodies at 1:1000 overnight at 4°C in the same solution. The blots were washed three times in PBS-Tween, and then incubated with mouse antibodies coupled to horse¬ radish peroxidase at 1:10 000 for 1 h at room temperature in PBS-Tween containing 1.5% BSA. Finally the blots were washed three times in PBS-Tween. Antibody complexes were detected by ECL using Kodak X-Omat XAR film.
RNA isolation
Total cellular RNA was prepared using a modification of the guanidine isothiocyanate method (Chirgwin et al, 1979) . Briefly, cells (approximately 10 ) were solubilized with guanidium isothiocyanate and layered onto a 8 ml cushion of caesium chloride and sedimented at 175 000 g for 20 h at 20°C, in a Beckmann SW 4lTi-rotor. RNA concentrations were deter¬ mined by UV absorption at 260 nm. The 28/18S ribosomal RNA integrity was assessed in agarose gel electrophoresis.
Reverse transcriptase-polymerase chain reaction (RT-PCR) Synthesis of cDNA was carried out with the Reverse-Transcriptor kit (R&D Systems Europe Ltd, Abingdon). Briefly, 2 pg of RNA were annealed to oligo d(T) primers. The cDNA was used immediately for PCR or stored at -20°C until use.
The selection of the polymerase chain reaction (PCR) primers was performed using the Wisconsin Package (Genetics Computer Group). On the basis of the human sequence for FP receptor (Abramovitz et al, 1994) , Got protein (Chen et al, 1996) and Gan protein (Jiang et al, 1991) the following oligonucleotides were chosen:
Forward and reverse primers for FP receptor were 1006 5'GTCTCCTGTATTTGTTGGAGCC and 1701 5'GAG CGGTGATCTCAAAATAACC, respectively. These primers would amplify a 696 bp fragment.
Forward and reverse primers for Get were 357 5' GGA CAGGAGAGAGTGGCAAG and 864 5'TTTCTTCTCTCT GACCTTTGGC, respectively. These primers would amplify a 508 bp fragment.
Forward and reverse primers for Gan were 383 5' GCT ACTCGGAGGAGGACAAG and 911 5' GACTCCACCAGG ACTTGGTC, respectively. These primers would amplify a 529 bp fragment.
PCR was performed in a final volume of 10 µ containing 100 ng cDNA, 10 mmol Tris-HCl 1" \ pH 8.3, 50 mmol KCI I-1, 1.5 mmol MgCl2 l-1, 0.001% (w/v) gelatin, 200 pmol of each deoxynucleotide triphosphate (dNTP) 1,1 pmol of each primer 1~1 and 0.25 U AmpliTaq DNA polymerase. The PCR reaction was: 94°C for 5 min, then 30 cycles of 94°C for 1 min, 60°C (for FP receptor) or 62°C (for Ga protein) or 59°C (for Gan protein) for 1 min and 72°C for 2 min, with a final elongation step of 72°C for 5 min. The products generated were subjected to electrophoresis on 1.5% agarose gel contain¬ ing ethidium bromide and visualized by UV irradiation. The identity of the fragments was verified by sequencing with thermo sequenase radiolabelled terminator cycle sequencing kit (Amersham International, Aylesbury).
Statistical analysis
Estimations were carried out with a minimum of four replicates and experiments were performed at least twice using granulosa cells obtained from different donors. Statistical com¬ parisons were performed using Student's t test. Differences were considered significant if < 0.05.
Results
Expression of FP receptor gene in human granulosa cells
The presence of FP receptor mRNA in human granulosa cells was demonstrated by RT-PCR analysis using FP receptorspecific primers that were designed to produce a 696 bp fragment. This resulted in the amplification of a single band for the three patients tested (Fig. 1 ). The identity of the PCR product was confirmed by sequencing which showed 100% homology with the published sequence for the FP receptor (Abramovitz et al, 1994 ).
Effects of fluprostenol on the formation of [ HjIPs and intracellular calcium concentration
Fluprostenol induced a concentration-dependent increase in total [3H]IPs, with an EC50 value of 26 nmol 1~1 and a maximal Fig. 1 . Expression of FP receptor gene in human granulosa cells. RT-PCR analysis of FP receptor produced the expected 696 bp band (lanes 2, 3 and 5; three different donors). A PCR sample without RNA transcribed product was loaded in lane 4 (blank). Lanes 1 and 6 contained DNA markers, the molecular size (bp) of which is given on the left. The identity of the PCR products was confirmed by sequencing. response at 1 pmol 1~1 (Fig. 2a ). Moreover fluprostenol increased [Ca +]¡ with an EC50 value of 12 nmol 1~ ( Fig. 2b) .
These results demonstrate that human granulosa cells possess a functional FP receptor with high affinity for fluprostenol. This receptor stimulates PLC and increases [Ca2+]¡ probably by Ca2+ mobilization from the endoplasmic reticulum, as supported by the fact that depletion of intracellular Ca2+ stores with thapsigargin (Thastrup et al, 1990) inhibited the rise in [Ca2+]¡ induced by fluprostenol (Fig. 2b insert) . Moreover, high extracellular Ca2+ was required for fluprostenol to have a full stimulatory effect (Fig. 2b insert) .
Identification of phospholipase C isoforms
The presence of phospholipase C isoforms in human granu¬ losa cells is demonstrated by Western blotting (Fig. 3a, b) . PLC-ßl migrated as two immunoreactive bands at 154 and 100 kDa. Preabsorbing anti-PLC-ßl with its cognate peptide resulted in the loss of both bands (Fig. 3a ). This indicates that the 100 kDa band is immunologically related to the main PLC-ßl. This isoform is known to be highly sensitive to proteolysis, even when cell extracts are freshly prepared in the presence of protease inhibitors (Suh et al, 1988; Park et al, 1993 ). PLC-ß2 and PLC-ß3 isoforms migrated at a molecular mass of approximately 140 and 155 kDa, respectively. Both bands were lost when the antibodies were first preincubated with their cognate peptides. The antibody raised against PLC-ß4 failed to detect this isoform (Fig. 3b ).
A strong band of 148 kDa corresponding to PLC-and a smaller band at 90 kDa which is immunologically related to PLC^2 were also detected (Fig. 3a, b ). All the PLC isoforms were found mainly in the cytosolic fraction, although PLC-ßl and PLC-1 appeared to be slightly associated with the membrane fraction.
Involvement of a PLC-ß pathway
The presence of PLC-ß isoforms in myometrial cells is in agreement with their involvement in G protein-mediated , 1993) . Pervanadate, an inhibitor of tyrosine phosphatases (Gordon, 1991) , was used to study PLCactivation in human granulosa cells and to compare the response to that of fluprostenol. Pervanadate provoked a high level of tyrosine phosphorylation as demon¬ strated by immunoblotting with anti-phosphotyrosine anti¬ body (Fig. 4) . The identity of the phosphorylated proteins was not determined, but they may represent proteins with molecu¬ lar mass similar to those of PLC-isoforms (for example 148 and 90 kDa). Neither fluprostenol nor oxytocin, the receptors of which operate through a G protein PLC pathway (Phaneuf et al, 1993) promoted tyrosine phosphorylation. Pervanadate stimulated IP formation fourfold over control and this effect was significantly inhibited by phenylarsine oxide (PAO), a compound that inhibits tyrosine phosphorylation (Yanaga et al, 1995) (Fig. 5 ). By contrast, the stimulatory effect of fluprostenol was not affected by PAO (Fig. 5 ). Furthermore, when cells were treated with PDBu, an activator of PKC, the PLC response to fluprostenol was almost abolished (Fig. 5 ), whereas the response to pervanadate was less affected. Acti¬ vation of PKC has an inhibitory feedback effect predominantly on G protein-linked PLC-ß activity (Biffen et al, 1993; Carrasco et al, 1996) . Taken together, these results suggest that the FP receptor in granulosa cells signals through a PLC-ß, rather than PLC-pathway. Cells were stimulated with agonists in the absence (control; D) or presence ( ) of PAO (1 µ 1" L) or PDBu (1 µ 1" '), which were added 5 and 10 min before the agonists, respectively. Results are expressed as relative change and are the mean + SD of quadrupli¬ cate determinations from single representative experiments. The findings were confirmed with cells from different donors. Statistical differences compared with cells without inhibitor: *, < 0.05; **, < 0.01.
Expression of Ga and Gan genes in human granulosa cells
For identifying the class of G protein involved in the mechanism of FP receptor activation, granulosa cells were pretreated with 0.5 pg pertussis toxin ml~for 16 h before being challenged with fluprostenol. The effect of fluprostenol was resistant to pertussis toxin (Fig. 6 ), indicating that it is mediated by a protein of the G family. Human granulosa cells have been shown to express G proteins of the G family as demonstrated by immunoblotting, although the antibody used could not distinguish between Got and Ga:l (López Bernal et al, 1995) . Here, we have demonstrated the presence of mRNA for both Ga and Gan in granulosa cells. RT-PCR analysis using Ga and Ga^-specific primers that were designed to produce a 508 bp and a 529 bp fragment, respect¬ ively, resulted in the amplification of single bands (Fig. 7) . The identity of the PCR products was confirmed by sequencing which showed 100% homology with the published sequences (Jiang et al, 1991; Chen et al, 1996) .
Discussion
The data reported here show that activation of FP receptors in human granulosa cells with the selective agonist fluprostenol results in a dose-dependent stimulation of PLC and an increase in [Ca2+]¡ concentrations and confirm that PGF2u may be an important physiological modulator of ovarian activity (McNatty et al, 1975; Thomas et al, 1978; Hamberger et al, 1979; Pate and Condon, 1984; Michael and Webley 1993) through a pathway that involves activation of the inositol phospholipid pathway. PGF2a operates through the FP receptor which has recently been cloned from human uterine tissues. This receptor displays the characteristic seven-transmembrane domains of G protein-coupled receptors (Abramovitz et al, 1994) . Binding studies with radiolabelled PGF2[1 indicated the presence of FP receptors in human luteal cells (Powell el al, 1974; Auletta el al, 1990; Olofsson and Leung, 1994) , and recently, Ristimäki et al. (1997) have cloned a partial cDNA sequence of the FP receptor from human granulosa cells. We have demonstrated the presence of FP receptor mRNA in Furthermore, in the present study we have shown that human granulosa cells express three subtypes of PLC-ß (ßl, ß2 and ß3) and two subtypes of PLC-( and 2) raising the possibility that FP receptors operate through tyrosine kinase as well as G protein-coupled pathways (Watanabe et al, 1994) .
In addition, we have demonstrated by RT-PCR that mRNAs for two pertussis toxin-resistant G proteins, Ga and Gan, are present in abundance in cultured granulosa cells. Since G proteins of the G family activate PLC-ß rather than PLCisoforms (Rhee and Choi, 1992) , it is suggested that in granulosa cells the FP receptor operates by increasing phosphoinositide formation and [Ca \ through a G /PLC-ß pathway. This is supported by the fact that despite the high expres¬ sion of PLCin cultured human granulosa cells, there was not stimulation of tyrosine phosphorylation in cells treated with the G protein receptor agonists fluprostenol or oxytocin. By contrast, pervanadate produced a marked increase in protein phosphorylation. Moreover, in the PLC activation assays the pattern of response to fluprostenol was very different from the response to pervanadate. Stimulation of PKC by phorbol ester inhibited the response to fluprostenol much more than the response to pervanadate. PLC-ß isoenzymes are very sensitive to PKC whereas the response to PLCenzymes is not affected (Biffen et al, 1993) . In addition, PAO, which blocks tyrosine phosphorylation of several proteins (Garcia-Morales et al, 1990; Anel and Kleinfeld, 1993; Yanaga et al, 1995) , inhibited the response to pervanadate without having any effect on the response to fluprostenol. These results clearly suggest that fluprostenol operates through a PKC-sensitive pathway such as PLC-ß that is not affected by blocking tyrosine phosphoryl¬ ation and does not involve PLC- (Carrasco et al, 1996) This contention is in agreement with the data published by Abayasekara et al (1993) and Michael et al (1993) who reported that the actions of PGF2(1 on human and marmoset luteal cells involve a PKC-dependent mechanism. FP receptors are hormonally regulated. In primates, the activation of PLC by PGF2o is enhanced as the luteal phase progresses (Houmard et al, 1992) ; however, by day 14 after ovulation the response to PGF2a or its analogue cloprostenol is lost, suggesting that in the primate corpus luteum recent exposure to LH or hCG is neccesary to stimulate PLC via FP receptors (Michael and Webley, 1993) . In sheep, FP receptor transcripts are high during the mid-luteal phase but decrease during luteolysis (Graves et al, 1995) . A similar pattern has been described for bovine FP receptors which are maximally induced 48 h after the ovulatory LH surge (Sakamoto et al, 1995; Tsai et al, 1996) . Interestingly, high levels of FP receptor transcripts are found in bovine corpus luteum during early pregnancy (Sakamoto et al, 1995) . Recent experiments in mice, suggest a role for FP receptors in luteal cell apoptosis (Hasumoto et al, 1997) Moreover, Ristimäki et al.
(1997) have shown that in human cultured granulosa cells FP receptor mRNA expression is stimulated by hCG through a cyclic AMP-dependent pathway and the effect of hCG was abolished with phorbol ester. Thus, activation of PKC not only inhibits the response of PLC-ß to the receptor, but also leads to receptor downregulation. Stimulation of FP receptor expression by LH/hCG and inhibition by PKC (which can be activated by PGF2(I itself) may provide a fine balance to regulate the activity and lifespan of the corpus luteum. In conclusion, human granulosa cells express an FP receptor which is functional and activates PLC-ß probably via a pertussis toxin-resistant G protein. Our results apply to mature granulosa cells obtained from stimulated IVF cycles after exposure to hCG in vivo and may not apply to granulosa cells at earlier stages of development or to late luteal cells. Further research is necessary to establish the role of FP receptors in the process of luteinization and luteolysis and to define the PLC-ß subtypes involved. An essential role for FP receptor-induced luteolysis in the initiation of par¬ turition has recently been shown in mice (Sugimoto el al, 1997).
